SIMABS

Agoralaan, Abis Abis /

3590 Diepenbeek

BE

SIMABS

Foundation date

22AUG2019

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

SIMABS is a start-up biotechnology venture that wants to develop a new bio-manufacturing platform to provide cost effective therapeutic monoclonal antibodies at small scale to biopharmaceutical companies.

Upcoming events

Latest news

  • Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease

    Thursday August 13th 2020

  • Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study

    Thursday August 13th 2020

  • BISC Global opens in Switzerland

    Wednesday August 12th 2020

Jobs by SIMABS